941710-30-1 Usage
Description
7-Bromocholesterol (7-BroMochroMan) is a synthetic compound that modulates cellular cholesterol metabolism, playing a crucial role in studying cholesterol trafficking, membrane organization, and functions within cells.
Uses
Used in Research Applications:
7-BroMochroMan is used as a research tool for investigating the mechanisms of cholesterol trafficking within cells. It disrupts the formation of lipid rafts, which are essential for cellular processes such as signal transduction, membrane transport, and protein trafficking.
Used in Cellular Physiology Studies:
7-BroMochroMan is used as a modulator of cellular cholesterol metabolism to study its impact on membrane organization and functions. It inhibits the intracellular transport of cholesterol, affecting its distribution and potentially influencing cellular homeostasis.
Used in Disease Research:
7-BroMochroMan is used in disease research to explore the role of cholesterol in cellular physiology and its association with various diseases. Its unique properties make it a valuable tool for investigating the underlying mechanisms and potential therapeutic targets related to cholesterol metabolism disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 941710-30-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,1,7,1 and 0 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 941710-30:
(8*9)+(7*4)+(6*1)+(5*7)+(4*1)+(3*0)+(2*3)+(1*0)=151
151 % 10 = 1
So 941710-30-1 is a valid CAS Registry Number.
941710-30-1Relevant articles and documents
SUBSTITUTED TRICYCLIC COMPOUNDS
-
Page/Page column 214, (2021/07/02)
Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, wherein, ring A, ring B, R1 to R4, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferative, infectious and RASopathy diseases or disorders. Also disclosed are methods of synthesizing the compound of formula I, pharmaceutical compositions containing the compound of formula I, method of treatment of proliferative, infectious and RASopathy diseases or disorder, for example, a cancer, by administering the said compound and combinations of the compound of formula I with other active ingredients.
MORPHOLINE CARBOXAMIDE PROKINETICIN RECEPTOR ANTAGONISTS
-
Page/Page column 42, (2008/06/13)
The present invention is directed to morpholine carboxamide compounds which are antagonists of prokineticin receptors, in particular antagonists of prokineticin 2 receptors, and which are useful in the treatment or prevention of neurological and psychiatr
